Market capitalization | SEK957.29m |
Enterprise Value | SEK815.39m |
P/E (TTM) P/E ratio | 16.94 |
EV/Sales (TTM) EV/Sales | 1.74 |
P/S ratio (TTM) P/S ratio | 2.04 |
P/B ratio (TTM) P/B ratio | 2.95 |
Revenue growth (TTM) Revenue growth | 10.46% |
Revenue (TTM) Revenue | SEK469.00m |
EBIT (operating result TTM) EBIT | SEK70.30m |
As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.
1 Analyst has issued a forecast C-Rad AB:
1 Analyst has issued a forecast C-Rad AB:
Dec '24 |
+/-
%
|
||
Revenue | 469 469 |
10%
10%
|
|
Gross Profit | 75 75 |
12%
12%
|
|
EBITDA | 76 76 |
14%
14%
|
EBIT (Operating Income) EBIT | 70 70 |
13%
13%
|
Net Profit | 57 57 |
23%
23%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
C-RAD AB engages in the development of innovative solutions for use in advanced radiation therapy. The company was founded by Jonas Erik Anders Hedlund in 2004 and is headquartered in Uppsala, Sweden.
Head office | Sweden |
CEO | Cecilia Leeuw |
Employees | 99 |
Founded | 2004 |
Website | www.c-rad.se |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.